Tag: Neuroguard
Contego Medical’s Neuroguard IEP system receives US FDA approval for carotid...
Contego Medical today announced the US Food and Drug Administration's (FDA) premarket approval (PMA) of the Neuroguard IEP system for carotid revascularisation.
The company shares...
First European PERFORMANCE II release highlights durability of carotid stenting in...
The recent, first-time European presentation of the PERFORMANCE II trial’s findings—delivered by Ralf Langhoff (Sankt Gertrauden-Krankenhaus, Berlin, Germany) at the 2024 Charing Cross (CX)...
Contego announces low one-year stroke rates in PERFORMANCE II carotid stent...
Contego Medical has announced the presentation of late-breaking clinical results from the PERFORMANCE II carotid stent trial at the annual Vascular Interventional Advances (VIVA)...
Contego announces enrolment of first patient in PERFORMANCE III trial
Contego Medical has announced enrolment of the first patient in the prospective, multicentre PERFORMANCE III trial aimed at further evaluating the safety and effectiveness...
Contego completes enrolment of PERFORMANCE II carotid stent trial
Contego Medical has announced that enrolment of the PERFORMANCE II clinical trial has been completed.
PERFORMANCE II is intended to evaluate the safety and effectiveness...
